Evidence map›Paper›PMID 31346562›Full record

ArticleJBMR plus2019

Profilin 1 Negatively Regulates Osteoclast Migration in Postnatal Skeletal Growth, Remodeling, and Homeostasis in Mice.

Jumpei Shirakawa, Shuhei Kajikawa, Ralph T Böttcher, Mercedes Costell, Yayoi Izu, Tadayoshi Hayata, Masaki Noda, Yoichi Ezura

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Update on the pathogenesis and genetics of Paget's disease of bone.Frontiers in cell and developmental biology · 2022
    Review
  11. Mutations in Profilin 1 Cause Early-Onset Paget's Disease of Bone With Giant Cell Tumors.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  12. Pharmacogenomics and personalized medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Jumpei ShirakawaDepartment of Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Shuhei KajikawaFrontier Research Unit Skeletal Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Ralph T BöttcherDepartment of Molecular Medicine Max Planck Institute of Biochemistry Martinsried Germany.
Mercedes CostellDepartment of Biochemistry and Molecular Biology Faculty of Biology University of Valencia Spain.
Yayoi IzuDepartment of Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Tadayoshi HayataDepartment of Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Masaki NodaDepartment of Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Yoichi EzuraDepartment of Molecular Pharmacology Medical Research Institute Tokyo Medical and Dental University Tokyo Japan.
Tokyo Medical and Dental University · JPMax Planck Institute of Biochemistry · DETsurumi University · JPUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Profilin 1 (Pfn1), a regulator of actin polymerization, controls cell movement in a context-dependent manner. Pfn1 supports the locomotion of most adherent cells by assisting actin-filament elongation, as has been shown in skeletal progenitor cells in our previous study. However, because Pfn1 has also been known to inhibit migration of certain cells, including T cells, by suppressing branched-end elongation of actin filaments, we hypothesized that its roles in osteoclasts may be different from that of osteoblasts. By investigating the osteoclasts in culture, we first verified that

Indexed as

BONE HISTOMORPHOMETRYDEVELOPMENTAL MODELINGDISEASES AND DISORDERS OF/RELATED TO BONEGENETIC ANIMAL MODELSOSTEOCLAST

Identifiers

PMID31346562
PMCPMC6636771
OpenAlexW2903292854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.